Trial Profile
Efficacy of Cilostazol for the treatment of Raynaud's Phenomenon in patients affected by Systemic Sclerosis
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 23 Jun 2011
Price :
$35
*
At a glance
- Drugs Cilostazol (Primary)
- Indications Embolism and thrombosis; Raynaud's disease
- Focus Therapeutic Use
- 23 Jun 2011 New trial record